These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 56448)

  • 21. Oncornavirus-like particles in squirrel monkey (Saimiri sciureus) placenta and placenta culture.
    Smith GC; Heberling RL; Helmke RJ; Barker ST; Kalter SS
    J Natl Cancer Inst; 1977 Sep; 59(3):975-9. PubMed ID: 408507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
    Metzgar RS; Mohanakumar T; Bolognesi DP
    J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of antiserum to the reverse transcriptase of Mason-Pfizer monkey virus.
    Harewood K; Ahmed M
    J Gen Virol; 1977 Aug; 36(2):227-35. PubMed ID: 70506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological properties of two polypeptides of Mason-Pfizer monkey virus.
    Tronick SR; Stephenson JR; Aaronson SA
    J Virol; 1974 Jul; 14(1):125-32. PubMed ID: 4134467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Further characterization of HeLa virus].
    Gelderblom H; Ogura H; Mölling K; Watson KF; Bauer H
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):426-34. PubMed ID: 4139841
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological evidence for antigenic differences between the Mason-Pfizer monkey virus (MPMV) and an MPMV-like virus (PMFV) detected in a malignant permanent human cell line.
    Micheel B; Baumbach L; Wunderlich V; Niezabitowski A; Bierwolf D
    Eur J Cancer (1965); 1979 Jan; 15(1):101-8. PubMed ID: 369867
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological characteristics of LPV oncornavirus produced by T-9 human cell line].
    Andzhaparidze OG; Liozner AL; Korchak OB; Mel'nikova NL; Lotte VD
    Vopr Virusol; 1975; (6):660-6. PubMed ID: 1226703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactivity of a normal human cell surface antigen with primate retrovirus glycoproteins.
    Sparrow RL; Purcell DF; McKenzie IF
    Hum Immunol; 1985 Jun; 13(2):83-93. PubMed ID: 3924865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of an antigen of the bovine C-type virus.
    McDonald HC; Graves DC; Ferrer JF
    Cancer Res; 1976 Apr; 36(4):1251-7. PubMed ID: 56993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of common antigenic determinants in the envelopes of mammalian type D (Mason--Pfizer) and type C virions by using the virion precipitation reaction].
    Al'tshteĭn AD; Zakharova LG; Zhdanov VM
    Vopr Virusol; 1978; (3):309-14. PubMed ID: 80888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins.
    Schochetman G; Kortright K; Schlom J
    J Virol; 1975 Nov; 16(5):1208-19. PubMed ID: 810603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationship of reverse transcriptases of primate type D retroviruses.
    Wunderlich V; Sydow G; Micheel B
    Arch Geschwulstforsch; 1980; 50(3):214-9. PubMed ID: 6159867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative antigenic analysis of J-96 cell oncornavirus and Mason-Pfizer virus from a spontaneous monkey mammary tumor].
    Kitsak VIa; Chuev IuV; Tikhonova ZN; Bektemirov TA
    Vopr Virusol; 1976; (2):203-6. PubMed ID: 180692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.
    Gottwein E; Bodem J; Müller B; Schmechel A; Zentgraf H; Kräusslich HG
    J Virol; 2003 Sep; 77(17):9474-85. PubMed ID: 12915562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competition radioimmunoassay for mason-pfizer monkey virus: comparison with recent isolates.
    Yen J; Ahmed M; Lyles J; Larson D; Mayyasi SA
    Int J Cancer; 1975 Apr; 15(4):632-9. PubMed ID: 49328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of Mason-Pfizer monkey virus in healthy rhesus monkeys.
    Ahmed M; Schidlovsky G; Korol W; Vidrine G; Cicmanec JL
    Cancer Res; 1974 Dec; 34(12):3504-8. PubMed ID: 4214612
    [No Abstract]   [Full Text] [Related]  

  • 37. Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey.
    Nowinski RC; Edynak E; Sarkar NH
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1608-12. PubMed ID: 4997759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic characteristics of transformed rhesus foreskin cells infected with Mason-Pfizer monkey virus.
    Fine DL; Peinta RJ; Malan LB; Kubicek MT; Bennett DG; Landon JC; Valerio MG; West DM; Fabrizio DA; Chopra HC
    J Natl Cancer Inst; 1974 Apr; 52(4):1135-42. PubMed ID: 4207874
    [No Abstract]   [Full Text] [Related]  

  • 39. Susceptibility of human cultured cells to Mason-Pfizer monkey virus.
    Ogura H; Ocho M; Tanaka T; Oda T
    Gan; 1978 Jun; 69(3):413-5. PubMed ID: 97115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic acid and protein studies of the Mason-Pfizer virus.
    Schlom J; Colcher D; Drohan W; Schochetman G
    Bibl Haematol; 1975 Oct; (43):134-40. PubMed ID: 822820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.